A prescription product to help people at risk of dying by suicide

The newest episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Seth Feuerstein ’94, founder of Oui Therapeutics, a company developing a digital therapeutic going through the FDA process and seeking to be the first prescription product available for people at risk of dying by suicide.

A psychiatrist and an attorney, Seth is also the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.

The Startup Cornell podcast, which launched in summer 2021, features interviews with Cornell entrepreneurs, who tell their stories of successes and failures and offer actionable advice for building and growing a business. It’s available on the Entrepreneurship at Cornell website, as well as Apple podcasts, Spotify and Soundcloud. It’s being created with help from Bert Odom-Reed of the Cornell Broadcast Studios and edited by Abigail Younger.

Past guests have included Barry Beck ’90, co-founder and former CEO of Bluemercury, Kim Hehir ’94, cofounder and president of Brutus Broth and Stephanie Wisner ’16, co-founder of Centivax.

/Public Release. View in full here.